Timeline
|
1897 |
Marcel Mérieux creates the Institut Mérieux, which developed a large range of vaccines and biological products, including reagents. Alain Mérieux was president of the Institut for 25 years, until 1994 |
|
|
1963 |
Creation of bioMérieux |
|
|
1986 |
API Systems (France) acquisition |
|
|
1988 |
Vitek acquisition from McDonnel Douglas (U.S.) |
|
|
2001 |
Organon Teknika Diagnostic acquisition from Akzo Nobel (Netherlands) |
|
|
2004 |
Listing of bioMérieux on the stock exchange |
|
|
2006 |
Inauguration of the Christophe Mérieux Center, dedicated to molecular biology and microsystems research (Grenoble, France) Bacterial Barcodes (U.S.) acquisition |
|
|
2007 |
Biomedics (Spain) acquisition BTF (Australia) acquisition |
|
|
2008 |
Joint venture with Sysmex (Japan) Joint venture with Shanghai Kehua Bio-engineering (China) AB BIODISK (Sweden) acquisition AviaraDx acquisition (U.S.) – renamed bioTheranostics PML Microbiologicals Inc. acquisition (U.S.) |
|
|
2009 |
Collaboration agreement with GlaxoSmithKline (United Kingdom) Strategic partnership with the French Atomic Energy Commission (CEA) |
|
|
2010 |
Collaboration agreement with Royal Philips Electronics (the Netherlands) Acquisition of Meikang Biotech (China) Acquisition of Shanghai Zenka Biotechnology (China) Strategic agreements with Shimadzu (Japan) and AnagnosTec (Germany) Strategic partnership with Biocartis (Switzerland) Strategic partnership with Knome (U.S.) Agreement with GlaxoSmithKline (United Kingdom) |
|
|
2011 |
Partnership with Ipsen (France) Acquisitions of AES Laboratoire and ARGENE (France) |
|
|
2012 |
Acquisition of RAS (India) |
|
|
2013 |
Acquisition of BioFire Diagnostics, Inc. (U.S.) |